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Abstract
Most epithelial ovarian cancers are diagnosed postmenopausally, although the well-established epidemiological risk
factors (parity, oral contraceptive use) are premenopausal. We hypothesized that accumulation of senescent fibro-
blasts, together with concomitant loss of presenescent fibroblasts within the ovarian cortex, promotes initiation
and early development of ovarian cancer from ovarian surface epithelial (OSE) cells. To test this, we established
immortalized OSE (IOSE) cell lines that mimic early neoplastic transformation by overexpressing the CMYC oncogene
(IOSECMYC) and normal ovarian presenescent (PSN) and senescent (SEN) fibroblast cell lines. We then evaluated the
ability of PSN and SEN fibroblasts to transform IOSE and IOSECMYC after coculture. SEN fibroblasts significantly
enhanced neoplastic development of IOSECMYC cells; there was an up to 15-fold increase in migration of IOSECMYC
cells cocultured with SEN fibroblasts compared with PSN fibroblasts. Conditioned medium from SEN fibroblasts pro-
moted anchorage-independent growth of IOSECMYC cells. We studied fibroblast-epithelial cell interactions in hetero-
typic three-dimensional spheroid models. Dual immunohistochemical staining of spheroids for a proliferation marker
(MIB-1) and cytokeratin-18 indicated that SEN fibroblasts induce approximately a five-fold increase in proliferation of
IOSECMYC cells relative to cocultures with PSN fibroblasts. SEN, but not PSN fibroblasts, also induced nuclear atypia in
epithelial cells in three-dimensional spheroids. These data suggest for the first time that the accumulation of senes-
cent, or loss of presenescent fibroblasts, can promote neoplastic development of partially transformed OSE cells
in vitro and illustrates the power of using three-dimensional heterotypic modeling to gain better insights into the etiol-
ogy underlying the development of epithelial ovarian cancer.
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Introduction
More than 80% of all epithelial ovarian cancers (EOCs) are diagnosed
in postmenopausal women older than 60 years [1,2]. However, the
strongest epidemiological risk factors for EOC are premenopausal factors
(oral contraceptive pill use and parity) [3,4]. High-grade serous tumors
are the most common histopathologic subtype of the disease but are
rarely diagnosed at an early stage, suggesting that these tumors progress
rapidly. One hypothesis to explain postmenopausal disease development
is that some as yet unknown microenvironmental trigger initiates prolif-
eration in dormant epithelial cells that harbor somatic mutation(s). One
possible trigger could be age-related changes (senescence) occurring in
ovarian stromal fibroblasts, which work in synergy with early genetic
changes in the epithelium to promote EOC development.
Abbreviations: NOF, normal ovarian fibroblast; INOF, immortalized NOF; SEN,
senescent NOF; PSN, presenescent NOF; OSE, ovarian surface epithelium; IOSE,
immortalized ovarian surface epithelium
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As an organism ages, senescent fibroblasts accumulate in the tissue
stroma, gradually replacing presenescent cells [5,6]. In vitro and in vivo
models have demonstrated that normal fibroblasts in a normal tissue
microenvironment can inhibit early tumorigenesis but that fibroblast
senescence results in a loss of inhibition of tumorigenesis and/or pro-
motion of epithelial transformation [7–9]. For example, senescent
fibroblasts enhance epithelial neoplastic progression in vitro and pro-
mote the formation of tumor xenografts in vivo in models of mammary,
prostate, and keratinocyte tumors [10–13]. Senescent cells do not di-
vide but remain metabolically active, and the profile of secreted proteins
in senescent cells differs substantially from their nonsenescent counter-
parts [14]. The induction of senescence induces a senescence-associated
secretory phenotype; senescent fibroblasts secrete a multitude of growth
factors (including vascular endothelial growth factor), extracellular ma-
trix proteins, proteases, chemokines, and cytokines [14,15]. It is likely
that these molecules act in paracrine to affect the phenotype of neigh-
boring epithelium, directly and indirectly, through remodeling of the
extracellular matrix and/or through interaction with other cell types
(e.g., inflammatory or endothelial cells) [8,16].
The aim of the current study was to investigate the role of aging
fibroblasts in the initiation and development of EOCs, using a three
dimensional model of cellular transformation of the ovarian surface epi-
thelium (OSE). We have previously established three-dimensional cell
culture models of normal, primary OSE cells and demonstrated their
biological similarities to primary tissues [17]. In the current study, we
created a three-dimensional heterotypic model of ovarian stromal-
epithelial cell interactions, and of the earliest stages of OSE transforma-
tion, to test the hypothesis that accumulation of senescent fibroblasts,
with concomitant loss of presenescent stromal cells, contributes to trans-
formation of ovarian epithelial cells. The results imply a role for senes-
cent fibroblasts in promoting early tumorigenesis of OSE and further
suggest that the ovarian stromal microenvironment may have a crucial
role in the development of EOCs.
Materials and Methods
Cell Culture, Retroviral Production, and Transduction
Primary normal ovarian surface epithelial (NOSE) cell isolates
NOSE4, NOSE11, and NOSE19L3 have been previously described
[17]. All ovarian epithelial cell cultures were maintained in NOSE
medium (NOSE-CM) [17]. Normal ovarian fibroblast (NOF) cells
were isolated from a patient undergoing total abdominal hysterectomy
for endometrial carcinoma. The ovary was confirmed as free of dis-
ease by a gynecological pathologist (E.B.). A tissue sample was excised
from the ovary and washed twice with phosphate-buffered saline (PBS;
from VWR, Lutterworth, UK) to remove loosely attached epithelial
cells. Tissue was then minced and incubated at 37°C/5% CO2 for 7
to 14 days to allow colony growth. Colonies with fibroblastic morphol-
ogies were isolated. Fibroblast cultures were maintained in basic me-
dium MCDB105/Medium 199 (1:1 ratio; both Sigma, St Louis, MO),
15% fetal bovine serum (FBS), and 1% L-glutamine (both Invitrogen,
Paisley, UK). To induce senescence, cells were exposed for 2 hours
to 80 μM of hydrogen peroxide solutions (VWR) diluted in culture
medium. β-Galactosidase bioactivity assays were performed as previ-
ously described [18]. Senescent fibroblasts were freshly prepared for
replicate experiments.
293T cells at 70% confluence were cotransfected with the
pVPack10A1, pVPackGP, and pBabe.hygro.hTERT/ pWZL.Blast.
CMYC (Addgene) vectors using FuGene6 transfection reagent (Roche,
Basel, Switzerland) at ratio of 3:1, reagent/DNA. The medium was
replaced 16 hours after transfection, and cultures were incubated for
a further 48 hours before retroviral supernatants were harvested and
stored at −80°C. To infect recipient cells, 3 ml of supernatant and
4 μg/ml DEAE-dextran (Sigma) were added to NOSE/NOF cells
at 30% to 50% confluence. Cells were split the following day, and
positive cells were selected with 10 to 30 U/ml hygromycin B (Merck,
Darmstadt, Germany)/2 to 3 μg/ml blasticidin (Sigma).
Immunofluorescent Cytochemistry and Immunohistochemistry
Immunofluorescent cytochemistry was performed using standard
protocols. The following antibodies were used at 1:1000 dilutions:
AE1/AE3 (Dako Corporation, Carpinteria, CA), cytokeratin 7 (CR-
UK, London, UK), BerEp4 (Dako), CA-125 (Dako), E-cadherin (Cell
Signaling, Danvers, MA), and fibroblast surface protein (FSP; Sigma).
Alexa Fluor 488–coupled secondary antimouse or antigoat antibodies
(Invitrogen) were used for antigen detection. Cells were counterstained
with Evans Blue (Sigma) diluted in H2O. Immunohistochemistry of
three-dimensional cultures was performed using standard protocols at
the UCL Advanced Diagnostics Laboratory. For analysis of MIB-1 and
cytokeratin 18 (Ck18) dual staining, the proportion of MIB-1+/Ck18+
cells were calculated relative to the total Ck18+ population of the culture,
using the following formula: relative % dual positive cells = (number
of MIB-1+/Ck18+ cells)/(total number of Ck18+ cells)] × 100%.
Telomere Length and Telomerase Activity Assays, In Vitro
Analysis of Tranduced Clones
To detect telomere length and telomerase activity, the TeloTAGGG
Telomere Length Assay and Telomerase PCR ELISAPLUS from Roche
were used according to the manufacturer’s protocols. For calculation of
relative telomerase activity, an hTERT-immortalized fibroblast cell line
(1BR3) was included as a positive control. Population doubling rates
were measured for 1 × 105 cells, in triplicate. Cultures were passaged,
and population doublings (PD) were calculated using the following for-
mula: PD = log (total cell number at each passage/initial cell number)/
log2. Anchorage-independent growth assays were performed as previ-
ously described [17]. Anchorage-dependent growth was assayed by plat-
ing 100 cells in six replicates onto 100-mm plates. Cells were refed
three times a week for 2 weeks and then fixed with methanol and
stained with Coomassie blue (Sigma). Colonies containing more than
10 cells were counted, and colony formation efficiencies were calcu-
lated using the following formula: colony-forming efficiency (CFE) =
[(number of colonies counted)/(number of cells plated)] × 100%.
Real-time Polymerase Chain Reaction
RNA extractions were performed using the QIAgen RNA extraction
kit with on-column DNase treatment. Samples were quantified and
reverse-transcribed using randomhexamer primers, according to standard
protocols. For real-time polymerase chain reaction (PCR), samples were
run according to manufacturer’s protocols: a FAM-labeled real-time
probe for CMYC (HS00153349_m1; Applied Biosystems, Carlsbad,
CA) was used with 18S rRNA probe as an internal control. Samples were
analyzed on an ABI 7900HT Fast Real-time PCR System (Applied Bio-
systems) and analyzed using the ΔΔC t relative quantification method.
Flow Cytometry
Cell cultures were trypsinized and centrifuged, and cell pellets were
resuspended in FACS buffer, with or without an anti–Annexin-FITC–
labeled antibody, according to the manufacturer’s instructions (Roche).
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Samples were run on a Becton Dickinson FACS Scan (Franklin Lakes,
NJ), and the Annexin V–positive population was measured. For cell
cycle analysis, cells were incubated with 1 mM 5-bromo-2-deoxyuridine
(BrdU; Sigma) for 2 hours. Cells were then washed in PBS and fixed
by dropwise addition of 70% ethanol with constant agitation. Sam-
ples were incubated at 4°C overnight before extraction of nuclei using
standard pepsin digestion protocols. Pelleted nuclei were incubated with
an anti-BrdU antibody (Becton Dickinson), washed twice with IFA
(10 mM HEPES pH 7.4, 150 mM NaCl, 0.1% sodium azide [all
Sigma]; 4% FBS [Lonza, Basel, Switzerland]) and then incubated with
an Alexa Fluor 488–coupled secondary antibody (Invitrogen). Washed
nuclei were resuspended 100 μg/ml propidium iodide (Sigma) in PBS
and analyzed as above.
Heterotypic Assays (Invasion, Migration, and
Three-dimensional Cell Culture)
Standard invasion and migration assays were modified to use pre-
senescent and senescent ovarian fibroblasts as a chemoattractant. A total
of 9 × 104 fibroblasts were plated in 24-well plates. The following
day, the cells were washed twice with PBS, and then 500 μl of serum-
free medium was added. Migration chambers (Greiner, Frickenhausen,
Germany) or rehydrated invasion chambers (Millipore, Billerica, MA)
were placed atop the fibroblast monolayers, and 3 × 104 (for migra-
tion assays) and 12.5 × 104 (for invasion assays) epithelial cells were
plated within the chamber. Assays were incubated at 37°C/5% CO2
for 24 hours before detection of invaded/migrated cells. For invasion
assays, invaded cells were detached from the membrane and lysed,
and a quantitative fluorimetric dye was added, using reagents from
the 24-well Chemicon QCM ECMatrix fluorimetric Invasion Assay
Kit (Millipore). Relative fluorescence units were read on a Varioskan
Flash plate reader (Thermo Scientific, Waltham, MA), and average val-
ues of a negative control (no cells) were deduced from each test well. For
migration assays, migrated cells were quantified as above, or membranes
were stained in situ with 1% crystal violet (Sigma) in 100% methanol,
washed twice with distilled water, and air-dried. The migrated cells
were counted in 10 fields of view per membrane. In all experiments,
10% FBS as a chemoattractant was also plated as a positive control.
Cells were grown as three-dimensional multicellular spheroids on
plastic dishes coated twice with a 1.5% solution of poly-2-hydroxyethyl
methacrylate (polyHEMA) from Sigma, prepared in 95% ethanol (also
Sigma). Fibroblasts were plated onto polyHEMA-coated plates and al-
lowed to form spheroids for 7 days before the culture was inoculated
with epithelial cells at a ratio of 4:1 fibroblasts-epithelial cells. Three-
dimensional heterotypic cultures were maintained in basic medium for
2 weeks and fed twice weekly before multicellular aggregates were
harvested, fixed in neutral-buffered formalin (VWR), processed into
paraffin, and stained by standard immunohistochemical techniques (at
the CR-UK Histology Service). For two-dimensional indirect coculture
assays, epithelial cells were plated into 24-well plates, and fibroblasts
were seeded into permeable tissue culture inserts (Greiner) at a ratio of
4:1 fibroblasts-epithelial cells. After 24 hours, the two cell types were
cocultured andmaintained for 14 days with twice-weekly refeeding. Epi-
thelial cells were then fixed with methanol and stained with crystal violet
(5 mg/ml in 2% ethanol), and cells lysed with 2% SDS/dH2O. Absor-
bance was then read at 595 nm on a Varioskan Flash plate reader.
Statistical Analysis
Where indicated, 2-tailed paired Student’s t-tests were performed.
Results
Normal Ovarian Fibroblasts Can Be Immortalized by the
Ectopic Expression of hTERT
PrimaryNOFs have a limited proliferative capacity in vitro. To address
this, we used ectopic overexpression of the catalytic subunit of human
telomerase (hTERT ) to extend the life span of primary NOF cells be-
yond 100 days without signs of replicative senescence (Figure 1A).
hTERT infected NOFs expressed telomerase, whereas primary NOFs
showed no telomerase activity, suggesting that NOFs had been im-
mortalized (INOFs; Figure 1B). Neither NOFs nor INOFs showed
any evidence of tumorigenic transformation, evaluated by anchorage-
independent growth. INOFs maintain expression of vimentin and FSP
and did not express the epithelial cell marker Ck7 (Figure 1C). There
was no expression of smooth muscle actin (SMA) in primary NOFs,
but SMA expression in INOFs indicated an activated phenotype, which
is consistent with other studies that show fibroblasts from other organs
become activated after hTERT immortalization (Figure 1C ) [19,20].
INOFs also maintained p16 expression, suggesting that loss of this cell
cycle checkpoint is not required for immortalization. Similar observa-
tions have been reported after immortalization of human mammary epi-
thelial cells, embryonic lung fibroblasts, and ovarian surface epithelial
(OSE) cells [21–25]. As part of this study, we also hTERT-immortalized
OSE (IOSE) cells derived from three different, normal, primary OSE
cultures (IOSE4, IOSE11, and IOSE19) using previously described
methods [17,24]. We confirmed that the primary OSE and IOSE cells
used in this study exhibit both epithelial and nonneoplastic character-
istics (Figure W1).
CMYC Overexpression Induces Neoplastic Transformation
of IOSE Cells
A complementary DNA encoding full-length CMYCwas introduced
into IOSE cells by retroviral transduction to induce the early stages of
neoplastic transformation. CMYC messenger RNA expression levels
were increased 80 to 500-fold in CMYC-infected IOSE cell lines
(IOSE4CMYC, IOSE11CMYC, and IOSE19CMYC). IOSECMYC cells
displayed altered cell morphology with cell size decreased, cell shape
more cuboidal, and cells more classically epithelial than IOSE cells.
IOSECMYC cells were tightly packed into a monolayer in traditional
two-dimensional cultures and lost the mesenchymal scattering pheno-
type that is characteristic of IOSE cells (Figure 2A). IOSECMYC cells
also showed increased CFEs in anchorage-dependent and anchorage-
independent growth assays (P ≤ .01; Figure 2, B and C ). CMYC
messenger RNA levels correlated with anchorage-independent CFE
(Pearson’s coefficient test, r2 = 0.8, P = .0156, α = 0.05). Flow cytome-
try showed significant reductions in the percentage of apoptotic cells
in IOSECMYC cell lines compared with the IOSE cell lines (P ≤ .05;
Figure 2D). A significantly greater proportion of IOSECMYC cells was
in G2 phase of the cell cycle (P ≤ .05; Figure 2E). These characteristics
are all consistent with the suggestion that IOSECMYC cells had under-
gone neoplastic transformation, although neither IOSE nor IOSECMYC
cells expressed the ovarian cancer markers E-cadherin and CA-125,
suggesting that IOSECMYC cells were only partially transformed.
Senescent Fibroblasts Enhance the Neoplastic Phenotype of
IOSECMYC Cells
We induced senescence in INOF cells by exposing the cells to low
dose levels of hydrogen peroxide (H2O2). H2O2 exposure reduced pro-
liferation of INOFs by approximately 30% and induced senescence,
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as shown by β-galactosidase expression (Figure 3A). We compared the
effects of H2O2-treated senescent fibroblasts (SEN) and untreated pre-
senescent fibroblasts (PSNs) on the invasive and migratory phenotypes
of IOSE and IOSECMYC cells. There was a 5.7- to 7.2-fold reduction
in transwell migration for all three IOSECMYC cell lines cocultured with
PSN fibroblasts relative to a serum control (P ≤ .01). In contrast,
migration levels increased 3.8- to 14.9-fold compared with serum con-
trols when IOSECMYC cells were cocultured with SEN fibroblasts
(Figure 3B). SEN fibroblasts also increased the invasive ability of
IOSECMYC cells compared with PSN fibroblasts (P ≤ .05; Figure 3C).
Neither PSN nor SEN fibroblasts had any significant effects on the
invasive ormigratory properties of IOSE cells. Finally, whenwe used con-
ditioned medium (CM) from cultured SEN fibroblasts in anchorage-
independent growth assays, we found that it increased the tumorigenic
phenotype of IOSE19CMYC cells relative to the same cells grown in
CM from PSN fibroblasts (P ≤ .05). Colony formation efficiencies of
IOSECMYC cells grown in PSN-CM or SEN-CM were significantly re-
duced relative to cells grown in standard growth medium (NOSE-CM,
P ≤ .05; Figure 3D).
Senescent Fibroblasts Enhance Epithelial Proliferation in
Three-dimensional Heterotypic Culture Models
Three-dimensional spheroid models of INOFs were generated by
culturing cells on polyHEMA-coated tissue culture plastics. INOFs
formed spontaneous aggregates within 48 hours of culture in non-
adherent conditions. Examination of formalin-fixed, paraffin-embedded
sections of 7-day-old INOF spheroids, stained with hematoxylin and
eosin (H&E), revealed that the central regions of spheroids contain pre-
dominantly acellular hyalinized nodules with apoptotic cells distributed
throughout a matrix-rich core. Peripherally, spindled cells with elongated
nuclei and an eosinophilic cytoplasm surround the spheroid. PSN and
SEN fibroblast spheroids were indistinguishable by H&E staining.
Seven-day-old INOF spheroid cultures were inoculated with IOSE
cells (INOF/IOSE cells ratio of 4:1) to establish three-dimensional
fibroblast-epithelial cell models. H&E examination of stained sections of
these heterotypic three-dimensional cultures showed central hyalinized
cores of abundant matrix protein (Figure 4, A and B). Spheroids con-
sisted of two morphologically distinct populations of cells, with either
spindled or plump cell morphologies. When IOSE cells were cultured
with SEN fibroblasts, we observed nuclear atypia within populations of
plump, peripheral cells and features such as irregular/enlarged nuclei,
prominent nucleoli and “giant” mononuclear cells within peripheral
regions of the spheroids (Figure 4A). These atypical features were not
present in spheroids generated from IOSE cells cultured with PSN
fibroblasts. There were also more prominent nucleoli and mitoses in
the plump cell populations from SEN-IOSECMYC cocultures compared
with PSN-IOSECMYC cocultures (Figure 4B). Finally, when IOSECMYC
cells were cocultured with PSN fibroblasts, we saw marked apoptosis
Figure 1. Extended life span of primary NOFs after hTERT immortalization. (A) Ectopic expression of hTERT increases the number of PDs of
NOFs to more than 30 PDs in INOFs. (B) Telomerase activity (relative to an internal positive control) is negligible in cell extracts from primary
NOFs but elevated in INOF cultures, and telomere terminal restriction fragment lengths are increased by approximately 2 kb after introduc-
tion of hTERT. (C) NOFs and INOFs both exhibit “spotty” positive staining with an anti-FSP antibody, which is characteristic of fibroblasts.
Both cell lines stain negative for Ck7. SMA is expressed in approximately 30% of INOF cells indicating a transition toward an activated
fibroblast phenotype with immortalization. Primary NOF cells did not express SMA, and this was independent of cell density. Both NOF
and INOF cells express p16 in the nucleus and cytoplasm (arrows). 4′,6-Diamidino-2-phenylindole (blue) stains cell nuclei, Evan’s blue (red)
stains the cell cytoplasm, and green fluorescence denotes positive staining. Note the spindled morphology of fibroblast cells. Exposure
times for immunofluorescent images were constant for each antigen. Error bars, SEM.
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in the central regions of spheroids, which was not present in SEN-
IOSECMYC cocultures (data not shown).
IOSE/INOF spheroids were compared with normal ovarian tissues
after staining for several epithelial and fibroblast markers. Only cyto-
keratin 18 (Ck18) reliably distinguished between ovarian fibroblasts
and epithelial cells. The fibroblastic markers vimentin, desmin, and pro-
line-4-hydroylase did not accurately discriminate between epithelial cells
and fibroblasts in normal ovarian tissue samples and spheroid cultures
(data not shown). In IOSE/INOF spheroids, epithelial cells could be
identified by Ck18 staining; IOSE cells formed a single cell layer sur-
rounding the fibroblast “core,” reminiscent of theOSEmonolayer in vivo
(Figure 4C ). However, in INOF-IOSECMYC cocultures, IOSECMYC cells
formed multiple cell layers surrounding the fibroblast core, with some
Ck18+ cells invading into the central regions of the spheroid (Figure 4,
E and F ). Dual immunohistochemical staining for Ck18 and the pro-
liferation marker MIB-1 highlighted the actively proliferating epithelial
proportion of culture (Figure 4, C–F ). In three-dimensional cocultures,
IOSECMYC cells were 0.03- to 12.8-fold more proliferative than IOSE
cells. In SEN-IOSECMYC spheroids, there was a 1.4- to 4.7-fold increase
in the relative percentage of IOSECMYC cell staining positive for both
Ck18 and MIB-1 relative to PSN-IOSECMYC cocultures (Figure 4G).
SEN/PSN fibroblasts did not significantly affect the proliferation of
epithelial cells in two-dimensional cocultures (Figure 4H ).
Discussion
The two most well-described risk factors for EOCs are the protective
effects conferred by pregnancy and oral contraceptive use [3,4]. It has
been postulated that both act by reducing the number of ovulations
throughout a woman’s lifetime, thus limiting the extent of rupture
and repair of the OSE [26]. However, ovarian cancer usually occurs
several years after menopause, and the natural history of high-grade
serous tumors (the most common histopathologic subtype) suggests
rapid and aggressive tumor growth. The microenvironmental trigger
for this is unlikely to be hormonal factors, given that postmenopausal
ovaries no longer producemitogenic steroid hormones (neither estrogens
nor androgens) [27]. Postmenopausal ovaries often show age-related
histopathologic changes, such as increased numbers of inclusion cysts
and deep invaginations of OSE into ovarian stroma, and it has been
hypothesized that these may be associated with neoplastic transforma-
tion [28]. We hypothesized that loss of presenescent stromal fibroblasts
and/or an accumulation of metabolically active but senescent fibroblasts
Figure 2. Immortalized OSE (IOSE) cell cultures overexpressing CMYC (IOSECMYC cells) show features of neoplastic transformation.
(A) The fibroblast-like elongated morphology of IOSE cultures changes to a more typically epithelial (cuboidal) morphology on CMYC
overexpression. Commitment to an epithelial phenotype is a hallmark of EOC cells. OSE cells in vitro and in vivo are able to switch
among epithelial, mesenchymal, and mesothelial phenotypes. (B) Overexpression of CMYC increases colony formation efficiency in both
anchorage-independent growth assays and in anchorage-dependent colony formation assays (C). (D) Staining with an anti–annexin V anti-
body followed by flow cytometry analysis reveals significantly fewer apoptotic cells in IOSECMYC cultures compared with parental cell lines.
(E) Cells were incubated with BrdU, and nuclei were stained with anti-BrdU. In CMYC-overexpressing cultures, there were significantly larger
proportions of cells in the G2 phase of the cell cycle compared with IOSE counterparts. In panels B to E, the differences for each phenotypic
assay between IOSE and IOSECMYC cells were statistically significant (P ≤ .05). Error bars, SEM.
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within the ovary create a microenvironment that can trigger neoplastic
transformation of dormant, partially transformed ovarian epithelial cells,
and that this is a possible explanation for the late-stage development
of ovarian cancers from an otherwise inactive organ. In support of this
hypothesis, we show for the first time that cellular changes in ovarian
stromal fibroblasts can promote neoplastic transformation of OSE cells.
This paracrine trigger acts in synergy with early genetic events in par-
tially transformed OSE cells but has little or no effect on untransformed
OSE cells.
We modeled the earliest stages of OSE transformation by over-
expressing the CMYC oncogene in hTERT-immortalized OSE cells
(IOSECMYC) because both hTERT and CMYC are commonly over-
expressed in EOCs [29,30]. IOSECMYC cell lines show evidence of
anchorage-independent growth but not invasion, confirming that they
are only partially transformed. We observed some variability in the re-
sponse of different cell lines toCMYCoverexpression, although thepheno-
typic trends were the same for all three cell lines; this variation may be
the result of subtle differences in the underlying genetic background of
the individuals from which the different cell lines were established, influ-
encing the phenotype. When we tested the effects of coculturing IOSE
and IOSECMYC cells with PSN and SEN fibroblasts, we found that
SEN fibroblasts had a significant effect on increasing neoplastic transfor-
mation of IOSECMYC cells compared with PSN fibroblasts; neither PSN
nor SEN fibroblasts appeared to transform IOSE cells. In anchorage-
independent growth assays, we also found that conditioned medium
taken from cultured SEN fibroblasts had the ability to promote the
neoplastic phenotype of IOSECMYC cells relative to the conditioned
medium harvested from PSN fibroblasts. Taken together, these data
suggest that the regulation of neoplastic epithelial cells by PSN/SEN
fibroblasts is mediated, at least in part, by soluble, secreted factors.
Key to performing these studies was our ability to generate and char-
acterize an immortalized NOF (INOF) cell line. To our knowledge,
this represents the first report detailing the generation of such a line.
We were able to confirm the normal, nontransformed, and fibroblastic
nature of this cell line, suggesting that it is a relevant model of NOFs.
Senescent fibroblasts were also created from the same INOF cell line
after exposure to hydrogen peroxide, and so it is unlikely that any of
the experimental differences we see between SEN and PSN fibroblasts
are the result of differences in the genetic background of cells taken
from different individuals.
Figure 3. Effects of PSN and SEN fibroblasts on the phenotype of IOSECMYC cells. (A) Exposing INOFs to hydrogen peroxide (H2O2) induces
a senescence response that is biologically similar to replicative senescence observed in aging organisms. β-Galactosidase bioactivity con-
firms senescence induction in INOFs: (i) 60% to 80% of SEN stain blue, (ii) untreated PSN fibroblasts do not stain, and (iii) crystal violet
growth assay (absorbance at 595 nm is relative to cell number) show that PSN fibroblasts are more proliferative than SEN fibroblasts. (B) In
a migration assay, PSN fibroblasts inhibited motility of IOSECMYC clones relative to 10% FBS. SEN fibroblasts significantly enhanced migra-
tion of allCMYC clones relative to a PSN fibroblast chemoattractant. (C) SEN fibroblasts enhanced invasive ability of IOSECMYC clones relative
to PSN fibroblast cells. (D) IOSE19CMYC cells proliferate significantly more in an anchorage-independent growth assay when incubated with
conditioned medium from SEN fibroblasts relative to PSN fibroblast conditioned medium. In both SEN/PSN–conditioned media, colony
formation efficiency of IOSECMYC cell lines was reduced relative to standard growth medium (NOSE-CM) (*P ≤ .05,**P ≤ .01 by Student’s
paired t-test). Error bars, SEM.
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Inducing senescence-like growth arrest after exposure to hydrogen
peroxide has been described previously, and senescent cells have sub-
sequently been shown to exhibit many of the features that are in common
with replicative senescence (e.g., β-galactosidase expression, G1 arrest,
enlarged morphology, transcriptomic changes) [12,23,31]. Other mech-
anisms of inducing cellular senescence can be considered including
exposure to bleomycin sulfate, but there is no evidence in the literature
to suggest that bleomycin offers an advantage over hydrogen peroxide
[12]. The limited life span of primary ovarian fibroblasts meant that their
immortalization using hTERTwas a necessary step, but immortalized
cells bypass replicative senescence, hence the need to perform chemically
induced senescence. This study therefore has its limitations because it is
unclear how closely stress-induced premature senescence in vitro, such as
that induced by hydrogen peroxide, reflects age-related senescence in vivo.
We were able to examine the morphological and biological char-
acteristics of epithelial-fibroblast interactions and to confirm the
neoplastic-promoting effects of senescent fibroblasts after creating a
three-dimensional heterotypic model of the ovary. This is the first time
that a heterotypic three-dimensional model of the normal ovary has
been described. In three-dimensional cultures, senescent fibroblasts en-
hanced proliferation and nuclear atypia in IOSECMYC cells relative to
presenescent and, to a lesser extent, the proliferation of IOSE cell lines.
Figure 4. Three-dimensional (3D) in vitro modeling of stromal-epithelial interactions. (A) In SEN-IOSE three-dimensional cocultures, “giant”
cells (arrow) were observed within peripheral regions of the spheroids. Spheroids contained abundant matrix protein “M.” (B) In SEN-
IOSECMYC three-dimensional coculture, there was a large peripheral region of plump cells containing some mitotic figures (arrows). (C–F)
INOF-IOSE cocultures dual stained for MIB-1 (pink nuclear stain, proliferation marker) and Ck18 (brown cytoplasmic stain). Unstained cells
are counterstained with hematoxylin (blue). (C) In SEN-IOSE cocultures, cytokeratin-positive cells are located in the peripheral region of the
spheroid (arrowhead). A Ck18+/MIB-1+ dual-positive cell (arrow) is visible in the largest spheroid. (D) In PSN-IOSE cocultures, nonspecific
staining ofmatrix protein can be distinguished by the absence of cellular structure. (E) SEN-IOSECMYC three-dimensional coculture viewed at
low magnification shows the central Ck18-negative staining fibroblastic population “F” and peripherally located Ck18-positive stained cells
within the spheroid. Some peripheral Ck18-positive stained cells, dual stained for MIB-1 (pink nuclei), can also be seen. (F) In SEN-IOSECMYC
three-dimensional cocultures negative Ck18 stain fibroblasts “C” closely interact with the population of Ck18-positive staining epithelial
cells “A” and “B.” Note the spindled morphology and elongated nucleus of Ck18-negative cells (e.g., cell C) compared with the plump mor-
phology and rounded nuclei of Ck18-positive cells. Cell A is positive for Ck18 and negative for MIB-1; cell B is positive for both Ck18 and
MIB-1. (G) Analysis of dual-stained Ck18/MIB-1–positive cells reveals enhanced proliferation in IOSECMYC cells when cocultured three-
dimensionally with SEN fibroblasts compared with PSN fibroblasts (*P ≤ .05, Student’s paired t-test). The proportion of MIB-1 cells is cal-
culated as a ratio of the total Ck18+ population of the culture. (H) Two-dimensional (2D) indirect coculture; crystal violet staining. Epithelial
cells do not show significant differences in rates of proliferation when cocultured with SEN or PSN fibroblasts.
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This suggests that even the earliest neoplastic changes in normal ovar-
ian epithelia may render cells susceptible to a tumor-promoting trigger
from the microenvironment. Our data also suggest that the synergistic
relationship between senescent fibroblasts and epithelial cells may con-
tinue as tumorigenesis progresses. This is consistent with studies by
Yang et al. [32] who have shown that inducing senescence in fibroblasts
increases the in vivo tumorigenicity of coinjected OSE cells expressing
SV40 large-T antigen.
If the results of these studies are real, and the accumulation of
metabolically active senescent fibroblasts does act as the microenviron-
mental trigger for ovarian cancer development, then it raises the
question, “what are the secretary factors responsible for epithelial cell
transformation?” Some candidates have been identified from previous
studies, including osteopontin, stromal cell–derived factor (SDF-1),
vascular endothelial growth factor, amphiregulin, hepatocyte growth
factor, and interleukin-6, all of which have been shown to act as medi-
ators of the differential paracrine effects of presenescent and senescent
fibroblasts [9,11–13,15]. The tumor-promoting effects of the condi-
tioned medium from SEN-IOSECMYC cocultures compared with the
medium from PSN-IOSECMYC cocultures suggest a possible biological
comparison that could be used to identify such factors in the future.
In conclusion, we have used an in vitro model of early-stage neo-
plastic transformation of normal ovarian epithelial cells to test the hy-
pothesis that the accumulation of senescent fibroblasts in aging ovaries
can act as a trigger to the rapid development of ovarian cancers—this
is consistent with many well-established epidemiological risk factors
for ovarian cancer. These effects may be due to the loss of an inhibitory
factor, secreted by normal fibroblasts, which inhibits carcinogenesis
of epithelial cells harboring mutation(s). Thus, loss of this inhibitory
signal on fibroblast senescence may create a microenvironment that is
permissive for tumor development. Alternatively, senescent fibroblasts
may produce factors that promote transformation of neoplastically
transformed epithelia. Support for this hypothesis has come from the
analysis of human ovarian tumors, which have been shown to contain
a large number of senescent fibroblasts within the tumor stroma; this
may also suggest a role for senescent fibroblasts in the maintenance
of ovarian tumors [32]. However, testing such a hypothesis in vivo in
normal ovaries is challenging. There are no reports of the rates of cel-
lular senescence in human ovaries and to study this would probably
require mass sectioning and analysis of large numbers of normal ovaries
to identify senescent cells. This may be possible using a β-galactosidase
bioactivity assay, which enables sensitive detection of senescent cells in
frozen tissue specimens. Another way to address the hypothesis, and
a focus of future studies, is to evaluate the tumorigenic phenotype of
three-dimensional heterotypic models of senescent and presenescent
fibroblasts with partially transformed normal ovarian epithelial cells
after implantation into immunosuppressed mice.
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Figure W1. Immortalization of primary NOSE cells. The three IOSE cell lines have been maintained in culture for more than 200 days with-
out signs of transformation: the cells do not grow in anchorage-independent growth assays and do not stain for CA-125 or E-cadherin,
which is commonly expressed in ovarian epithelial tumors. (A) In vitro life span of primary NOSE cells is typically around 50 days. Immor-
talized OSE (IOSE) cells have been passaged for more than 200 days to date. Primary cells were immortalized by the ectopic expression of
hTERT. (B) Telomere terminal restriction fragment length is increased in IOSE cell lines compared with parental NOSE cultures. (C) Telome-
rase activity, detected by PCR-ELISA, is absent in primary cultures but present in immortalized cell lines. (D) Staining for cytokeratin (Ck7),
BerEP4, CA-125, E-cadherin, pan-cytokeratin (AE1/AE3), FSP, and calretinin by fluorescent immunocytochemistry reveals that primary NOSE
and IOSE have similar staining profiles.
